Tara M. Robinson - Concepedia

Author

Tara M. Robinson

Also Known As

Lowe, Gillian, T M Robinson, T Robinson, T. Robinson, T.M. Robinson, Tamaraty Robinson, Tanya Sudia Robinson, Tara M Robinson, Tara M. Robinson, Tara Robinson

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania BioMarin (United States)Bioqual National Cancer Institute Guy's and St Thomas' NHS Foundation Trust

About

Tara M. Robinson is an author at University of Pennsylvania specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	632
2	Immunology	6	6	611
3	Cell Biology	3	3	472
4	Biomedical Engineering	1	1	127
5	Cellular Therapies	1	1	11

Tara M. Robinson

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells Michael A. Chattergoon, Tara M. Robinson, Jean Boyer, The Journal of Immunology Adaptive Immune SystemAdaptive Immune ResponseInnate Immune SystemImmunologyImmunologic Mechanism	1998	221
Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help Michele A. Kutzler, Tara M. Robinson, Michael A. Chattergoon, The Journal of Immunology	2005	183
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A Johnny Mahlangu, Radosław Kaczmarek, Annette von Drygalski, New England Journal of Medicine	2023	176
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production Jing Du, Katelyn Paz, Ryan Flynn, Blood	2017	150
Targeted antigen delivery to antigen–presenting cells including dendritic cells by engineered Fas-mediated apoptosis Michael A. Chattergoon, J. Joseph Kim, Joo-Sung Yang, Nature Biotechnology MedicineImmunologyAntigen ProcessingImmunotherapeuticsBiomedical Engineering	2000	127
A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity S. Hayley, Bibhav Poudel, Evanthia T. Roussos Torres, Cancer Immunology Research T-cell–mediated Anticancer ActivityAntagonist MabsImmunologyImmunoeditingImmunotherapeutics	2019	124
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A John Pasi, Michael Laffan, Savita Rangarajan, Haemophilia	2021	95
SIV DNA vaccine co‐administered with IL‐12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques Jean Boyer, Tara M. Robinson, Michele A. Kutzler, Journal of Medical Primatology	2005	94
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure Amer M. Zeidan, Hanna A. Knaus, Tara M. Robinson, Clinical Cancer Research	2018	94
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid Jean Boyer, Tara M. Robinson, Michele A. Kutzler, Proceedings of the National Academy of Sciences ImmunologyImmunodominanceCd4 T Cell ResponsesShiv AntigenNonhuman Primates	2007	87

Page 1